CEPHEID (CPHD) SVP, CFO Andrew Miller sells 2,500 Shares

SVP, CFO of CEPHEID (CPHD, Financial) Andrew Miller sells 2,500 shares of CPHD on 02/14/2011 at an average price of $25.43 a share.

Cepheid has a market cap of $1.53 billion; its shares were traded at around $25.34 with and P/S ratio of 7.2.

Hedge Fund Gurus that owns CPHD: Manning & Napier Advisors, Inc, Steven Cohen of SAC Capital Advisors. Mutual Fund and Other Gurus that owns CPHD: Columbia Wanger of Columbia Wanger Asset Management, PRIMECAP Management, Mario Gabelli of GAMCO Investors.

CFO Recent Trades:

  • Sell: SVP, CFO Andrew Miller sold 2,500 shares of CPHD stock on 02/07/2011 at the average price of 24.43. The price of the stock has increased by 3.72% since.

  • Sell: SVP, CFO Andrew Miller sold 10,000 shares of CPHD stock on 12/08/2010 at the average price of 23.43. The price of the stock has increased by 8.15% since.



Directors and Officers Recent Trades:

  • Sell: Exec VP,Chief Med/Tech Officer David H Persing sold 20,000 shares of CPHD stock on 02/10/2011 at the average price of 24.62. The price of the stock has increased by 2.92% since.

  • Sell: Director Thomas L Gutshall sold 23,094 shares of CPHD stock on 02/01/2011 at the average price of 23.98. Thomas L Gutshall owns at least 927,766 shares after this. The price of the stock has increased by 5.67% since.

  • Sell: Director Thomas L Gutshall sold 1,000 shares of CPHD stock on 01/27/2011 at the average price of 25.09. Thomas L Gutshall owns at least 927,766 shares after this. The price of the stock has increased by 1% since.

  • Sell: Director Thomas L Gutshall sold 1,000 shares of CPHD stock on 12/27/2010 at the average price of 23.29. Thomas L Gutshall owns at least 928,766 shares after this. The price of the stock has increased by 8.8% since.

  • Sell: Director Thomas L Gutshall sold 1,000 shares of CPHD stock on 11/29/2010 at the average price of 19.95. Thomas L Gutshall owns at least 930,766 shares after this. The price of the stock has increased by 27.02% since.




For the complete insider trading history of CPHD, click here.